Oracle's Put Buyers Are Right So Far, But Stephens Just Raised Its Flag

Why this matters now: ORCL dropped another 8.8% on Monday to $119.22, extending a brutal slide that has now erased 16% over the past month. Three separate signals converged on the same day: an analyst upgrade, a sharp rise in put-buying, and a cost-to-borrow spike. They are pointing in opposite directions, and the divergence is the story.

Hedgers Accelerate, Stephens Steps In

The put/call ratio hit 0.9747 on November 2, 2.2 standard deviations above its 20-day mean of 0.89. That is close to the 52-week high of 1.06, and the sharpest one-day jump in the options market this stock has seen in recent months. Protection-buying has been building since early October, when the ratio sat in the 0.82 to 0.84 range. It has risen almost every session since. The earnings bounce on October 28 did not reset it.

One day before the fresh selloff, Brett Huff at Stephens upgraded ORCL to Overweight from Equal-Weight and lifted his price target to $213 from $185. At the $130.67 close on November 2, that implied 63% upside. At today's $119.22, the gap is wider still. The broader analyst community has not wavered: TD Cowen sits at $240, Oppenheimer at $275, Cantor Fitzgerald at $284. The consensus remains buy, with a mean target of $233.

Cost to Borrow Jumps, Borrow Market Stays Open

Cost to borrow rose 95% over the past week to 0.28%. In isolation that looks alarming. In context it reflects a very different dynamic. Shares available to borrow remain at the absolute ceiling for this dataset. The borrow market is essentially frictionless for anyone wanting to establish or add to a short position. Short interest sits at 1.7% of the free float, essentially unchanged over the past month. The cost-to-borrow spike is a reaction to the price move and near-term volatility, not evidence of crowded shorting or borrow scarcity. Capital Research added 10.3 million shares in the last reported quarter, the largest institutional addition in the top-holder list.

Peers and the Wider Slide

ORCL fell 5.4% over the past week. Its closest peers fared worse: the median peer decline was 9.0%. NTNX dropped 11.4%, IREN fell 13.4%, and NBIS lost 8.3%. Only one peer, REKR, posted a gain over the week, up 42.8% on idiosyncratic news. The sector is under broad pressure.

The backdrop for ORCL specifically remains the $20 billion capital raise announced November 3, split between a $10 billion equity offering and $10 billion in senior notes. As the previous report noted, that raise reopened dilution questions at an already difficult moment for the stock.

What to Watch

The next earnings date is November 18. That is 15 days away. The put/call ratio's current trajectory, and whether it breaks toward the 52-week high of 1.06, will indicate whether options traders are bracing for the print or simply hedging the ongoing slide. The gap between today's price and the lowest analyst target on the board ($205, Freedom Broker) is now around 72%.